Daronrix

Country: European Union

Language: Slovenian

Source: EMA (European Medicines Agency)

Buy It Now

Public Assessment Report Public Assessment Report (PAR)
02-07-2013

Active ingredient:

Celotno virion, inaktivirano, ki vsebujejo antigen*: A/Vietnam/1194/2004 (H5N1)* proizvedeni v jajca

Available from:

GlaxoSmithKline Biologicals S.A.

ATC code:

J07BB01

INN (International Name):

pandemic influenza vaccine (whole virion, inactivated, adjuvanted)

Therapeutic group:

Cepiva

Therapeutic area:

Influenza, Human; Immunization; Disease Outbreaks

Therapeutic indications:

Preprečevanje gripe v uradno prijavljeni pandemični situaciji. Pandemije gripe cepiva je treba uporabljati v skladu z uradnimi smernice.

Authorization status:

Umaknjeno

Authorization date:

2007-03-21

Similar products

Active ingredient Celotno virion, inaktivirano, ki vsebujejo antigen*: A/Vietnam/1194/2004 (H5N1)* proizvedeni v jajca

Celotno virion, inaktivirano, ki vsebujejo antigen*: A/Vietnam/1194/2004 (H5N1)* proizvedeni v jajca

ATC code J07BB01

J07BB01

Marketed by GlaxoSmithKline Biologicals S.A.

GlaxoSmithKline Biologicals S.A.

INN (International Name) pandemic influenza vaccine (whole virion, inactivated, adjuvanted)

pandemic influenza vaccine (whole virion, inactivated, adjuvanted)

Documents in other languages

Patient Information leaflet Patient Information leaflet Bulgarian 02-07-2013
Summary of Product characteristics Summary of Product characteristics Bulgarian 02-07-2013
Public Assessment Report Public Assessment Report Bulgarian 02-07-2013
Patient Information leaflet Patient Information leaflet Spanish 02-07-2013
Summary of Product characteristics Summary of Product characteristics Spanish 02-07-2013
Public Assessment Report Public Assessment Report Spanish 02-07-2013
Patient Information leaflet Patient Information leaflet Czech 02-07-2013
Summary of Product characteristics Summary of Product characteristics Czech 02-07-2013
Public Assessment Report Public Assessment Report Czech 02-07-2013
Patient Information leaflet Patient Information leaflet Danish 02-07-2013
Summary of Product characteristics Summary of Product characteristics Danish 02-07-2013
Public Assessment Report Public Assessment Report Danish 02-07-2013
Patient Information leaflet Patient Information leaflet German 02-07-2013
Summary of Product characteristics Summary of Product characteristics German 02-07-2013
Public Assessment Report Public Assessment Report German 02-07-2013
Patient Information leaflet Patient Information leaflet Estonian 02-07-2013
Summary of Product characteristics Summary of Product characteristics Estonian 02-07-2013
Public Assessment Report Public Assessment Report Estonian 02-07-2013
Patient Information leaflet Patient Information leaflet Greek 02-07-2013
Summary of Product characteristics Summary of Product characteristics Greek 02-07-2013
Public Assessment Report Public Assessment Report Greek 02-07-2013
Patient Information leaflet Patient Information leaflet English 02-07-2013
Summary of Product characteristics Summary of Product characteristics English 02-07-2013
Public Assessment Report Public Assessment Report English 02-07-2013
Patient Information leaflet Patient Information leaflet French 02-07-2013
Summary of Product characteristics Summary of Product characteristics French 02-07-2013
Public Assessment Report Public Assessment Report French 02-07-2013
Patient Information leaflet Patient Information leaflet Italian 02-07-2013
Summary of Product characteristics Summary of Product characteristics Italian 02-07-2013
Public Assessment Report Public Assessment Report Italian 02-07-2013
Patient Information leaflet Patient Information leaflet Latvian 02-07-2013
Summary of Product characteristics Summary of Product characteristics Latvian 02-07-2013
Public Assessment Report Public Assessment Report Latvian 02-07-2013
Patient Information leaflet Patient Information leaflet Lithuanian 02-07-2013
Summary of Product characteristics Summary of Product characteristics Lithuanian 02-07-2013
Public Assessment Report Public Assessment Report Lithuanian 02-07-2013
Patient Information leaflet Patient Information leaflet Hungarian 02-07-2013
Summary of Product characteristics Summary of Product characteristics Hungarian 02-07-2013
Public Assessment Report Public Assessment Report Hungarian 02-07-2013
Public Assessment Report Public Assessment Report Maltese 02-07-2013
Public Assessment Report Public Assessment Report Dutch 02-07-2013
Public Assessment Report Public Assessment Report Polish 02-07-2013
Public Assessment Report Public Assessment Report Portuguese 02-07-2013
Public Assessment Report Public Assessment Report Romanian 02-07-2013
Public Assessment Report Public Assessment Report Slovak 02-07-2013
Patient Information leaflet Patient Information leaflet Finnish 02-07-2013
Summary of Product characteristics Summary of Product characteristics Finnish 02-07-2013
Public Assessment Report Public Assessment Report Finnish 02-07-2013
Public Assessment Report Public Assessment Report Swedish 02-07-2013

Search alerts related to this product

Alerts Daronrix Celotno virion, inaktivirano, vsebujejo pandemic influenza vaccine

Daronrix Celotno virion, inaktivirano, vsebujejo pandemic influenza vaccine

View documents history

Documents history Documents history

Daronrix